HEALIUS LIMITED — Director's Dealing 2024

May 16, 2024

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	HEALIUS LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Charles Taylor
Date of last notice	18 March 2024

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

hispart.
Direct or indirect interest	Direct and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	As shown
Date of change	14 May 2024
No. of securities held prior to change	100,000 Ordinary Shares 16,450 NED Restricted Ordinary Shares 16,450 NED Share Rights
Class	Ordinary Shares
Number acquired	16,450
Number disposed	16,450
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Nil - a transfer of NED Restricted Shares to the custodian under the Healius NED Share Plan.

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	100,000 Ordinary Shares - Charles Taylor 16,450 NED Share Rights – Charles Taylor 16,450 Ordinary Shares - Citicorp Nominees Pty Limited on behalf of CPU Share Plans Pty Ltd for Charles Taylor as beneficial owner.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back	Transfer of NED Restricted shares to the custodian under the Healius NED Share Plan.

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written N/A clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date was N/A this provided?

Authorised by the Company Secretary.

Mary Weaver Company Secretary Date: 17 May 2024

• See chapter 19 for defined terms.

Appendix

3Y

Page

2